ARCHIVES

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Northwestern To Test Method To Detect Colon Cancer

February 25, 2005

Gallo Breakthrough On AIDS Etiology To Be Reported Soon

April 20, 1984

Two Avastin Trials Show OS Benefit In Advanced Disease

August 27, 2010

Also in this 12-page issue: Senate report endorses NCI’s 2015 goal.

July 22, 2005

Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting

June 20, 1986

In Brief: Murphy New ACS President, Robert McKenna Named President Elect Gehan Receives Gottlief Award

November 18, 1983